clinical trial · NCT02039557
Long Term Follow Up Protocol for NiCord®/CordIn™ (Omidubicel) Patients
Patients Transplanted With NiCord/CordIn (Omidubicel)NiCord®/CordIn™ (omidubicel)
brief summary
This is an observational study that will monitor clinical outcomes of patients who have received a NiCord®/CordIn™ (omidubicel) transplant as part of a GC clinical interventional study and meet the eligibility criteria for this Long Term Follow Up study.
started
May 1, 2014
primary completion
Jun 29, 2023
completion
Jun 29, 2023
last updated
Oct 23, 2024
official title
Long Term Follow Up for Patients Who Have Received Allogeneic Stem Cell Transplantation of NiCord®/CordIn™, Umbilical Cord Blood-derived Ex Vivo Expanded Stem and Progenitor Cells
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol